MRK vs ABBV
MRK and ABBV side by side — valuation & fundamentals (public data).
Key statistics
| Metric | MRKMerck & Co., Inc. | ABBVAbbVie Inc. |
|---|---|---|
| Market cap | $362.85B | $464.15B |
| P/E (TTM) | 117.7 | 74.2 |
| P/B | 8.65 | — |
| P/S | 5.6x | 7.6x |
| Dividend yield | 2.25% | 2.51% |
| Revenue | $66.57B(TTM) | $61.16B(TTM) |
| Revenue growth (YoY) | 1.3% | 8.6% |
| Net income | $3.17B(TTM) | $6.31B(TTM) |
| Earnings growth (YoY) | 6.6% | -1.2% |
| EPS, diluted | $1.25(TTM) | $3.54(TTM) |
| EBIT margin | 34.2% | 24.6% |
| ROE | 43.5% | — |
| ROIC | 21.6% | 18.6% |
| 1y total return | +85.3% | +22.2% |
Figures from SEC filings · for reference only · not investment advice
Growth of $10,000: MRK vs ABBV
| Metric | MRK | ABBV |
|---|---|---|
| End value | $37.1K | $64.0K |
| Total return | +270.7% | +539.5% |
| CAGR | +13.5% | +19.7% |
| Volatility | 23.3% | 25.9% |
| Sharpe | 0.48 | 0.67 |
| Sortino | 0.71 | 0.93 |
| Max drawdown | -43.4% | -45.1% |
Based on 2600 common trading days, 2016-05-16 → 2026-09-17 · risk-free 4.14% (current short-Treasury, held constant)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)